Compare Avantis US Small Cap Value ETF (AVUV) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avantis US Small Cap Value ETF vs 10X Genomics Inc — how do they compare? Avantis US Small Cap Value ETF trades at $127.58, while 10X Genomics Inc trades at $59 (market cap $7.61B). Which is the better fit depends on your goals.
| AVUV | TXG | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $128.74 | $58.57 |
52-Week Low | $93.93 | $11.34 |
Market Cap | — | $7.61B |
Enterprise Value | — | $7.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Avantis US Small Cap Value ETF
AVUV is an actively managed ETF that targets small-cap value companies in the United States. It uses a systematic, rules-based process to identify firms with low valuations and high profitability, aiming to capture the historical premiums of 'size' and 'value' while filtering for financial quality.
Read more on AVUV →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
